Hepatitis E virus (HEV) is a causative agent of acute hepatitis and a major public health problem in India. There are four mammalian HEV genotypes worldwide. In India, genotype 1 (HEV-1) is restricted to humans whereas genotype 4 (HEV-4) circulates in pigs. Studies from our laboratory have shown that HEV-4 (swine) virus can establish experimental infection in rhesus monkeys; however, HEV-1 (human) virus cannot infect pigs. Viral and/or cellular factors responsible for this host specificity are not yet known. We developed 12 different genotype 1-4 chimeric full genome clones with pSK-HEV2 as the backbone and by replacing structural (ORF2 and ORF3), nonstructural (ORF1) and non-coding regions (NCR) with corresponding segments from the HEV-4 clone. S10-3 (human hepatoma) and PK-15 (pig kidney) cells were transfected with transcripts generated from the above clones to test their replication competence. Transfected cells were monitored for successful virus replication by detecting replicative intermediate RNA and capsid protein (immunofluorescence assay). All the chimeric constructs were able to replicate in S10-3 cells. However, only two chimeric clones, HEV-1 (HEV-4 5¢NCR-ORF1) and HEV-1 (HEV-4 ORF1), containing 5¢NCR-ORF1 and ORF1 regions from the HEV-4 clone, respectively, were able to replicate in PK-15 cells. We demonstrate for the first time the crucial role of ORF1 polyprotein in crossing the species barrier at the cellular level. These results indicate the importance of interactions between ORF1 protein domains and host cell specific factors during HEV replication and the critical role of cellular factors as post-entry barrier/s in virus establishment.
INTRODUCTION
Hepatitis E virus (HEV) belongs to the genus Orthohepevirus in the family Hepeviridae. The species Orthohepevirus A includes all viral variants known to infect humans (presently known as genotypes 1-4) (Smith et al., 2014) . The HEV genome is a single stranded positive sense polyadenylated RNA. Except avian HEV (6.8 kb), the average genome size is~7.2 kb. The genome is capped at its 5¢ end and contains three overlapping ORF -namely ORF1, ORF2 and ORF3 (Tam et al., 1991) . The viral genome is flanked by short 5¢ and 3¢ UTRs and a conserved 58 nt region within ORF1; these elements are likely to fold into conserved stem-loop and hairpin structures. Genotypes 1 and 2 are restricted to humans, while genotypes 3 and 4 are zoonotic (Pavio et al., 2010; Meng, 2011) .
The genotype 3 strain of human HEV can infect pigs and the genotype 3 swine HEV strain is able to establish successful infection in non-human primates. However, genotype 1 or 2 human HEV strains are not able to infect pigs under experimental conditions (Meng et al., 1998a) . Successful experimental infections of non-human primates with genotype 3 and 4 swine HEV further prove the ability of these viruses to infect humans (Meng et al., 1998b; Arankalle et al., 2006) . Vice versa, pigs can be experimentally infected with genotype 3 (Halbur et al., 2001) and genotype 4 (Feagins et al., 2008) human HEV strains. These studies show that pigs are refractory to human genotype 1 and 2 HEV.
Incorporation of 3¢ non-coding region (NCR) sequences of the swine strain of HEV (genotype 3) into the genotype 1 human strain does not enable the chimeric virus to infect swine . Feagins et al. (2011) developed chimeric virus constructs by swapping genomic regions of genotype 1, 3 and 4 viruses and demonstrated that chimeric viruses containing the ORF2 gene, either alone or in combination with its adjacent 5¢ junction region (JR) and 3¢ NCR from genotype 4 human HEV, in the backbone of genotype 3 swine HEV are replication-competent in Huh7 cells and infectious in HepG2/C3A cells and in pigs. However, chimeric viruses containing the JR+ORF2 +3¢NCR of either genotype 3 or 4 HEV in the backbone of genotype 1 human HEV failed to infect pigs, suggesting the possible role of other genomic regions such as 5¢ NCR and ORF1 in HEV cross-species infection. This study was further extended by Córdoba et al. (2012) . They constructed two chimeric viruses: (a) JR+ORF2+3¢NCR of genotype 1 human HEV in the genotype 4 human HEV infectious clone backbone, and (b) JR+ORF2+3¢NCR of genotype 1 human HEV in the genotype 3 swine HEV infectious clone backbone. They also tested infectivity of chimeras (c) JR+ORF2+3¢NCR of genotype 4 human HEV in the genotype 1 human HEV infectious clone backbone, and (d) JR+ORF2+3¢NCR of genotype 3 swine HEV in genotype 1 human HEV infectious clone backbone, developed earlier (Feagins et al., 2011) , by direct intra-hepatic inoculation of the transcripts in pigs. All four constructs were replicationcompetent in Huh7 cells. However, the RNA transcripts from chimeras made with genotype 1 virus backbone, failed to infect pigs. Moreover, the two chimeras developed with genotype 3 and 4 virus backbones also failed to replicate in pigs, except for one pig. The species specificity of HEV with respect to viral genomic regions still remains elusive.
In this study, we constructed an infectious cDNA clone from a genotype 4 (swine) virus which is currently circulating in India. Further, we constructed chimeric clones by replacing different genomic regions of the parental genotype 1 construct with that of the genotype 4 virus and checked replication competence of the clones in human and swine cells. We conclude that the non-structural (ORF1) region may play an important role in deciding species specificity.
RESULTS

Construction of genotype 4 full genome clone and its replication competence in vitro
The full genome clone HEV-4FG had T7 promoter at the 5¢ end and Bam HI site (for linearization immediately downstream to viral poly A sequence) at the 3¢ end. Since the cDNA clone would be used as a donor for genotype 4 genes for construction of chimeras it was essential to test the replication competence and infectious particle generation of the clone. For that, S10-3 cells were used as they are known to support replication of both genotype 1 and genotype 4 HEV. RNA generated from pSK-HEV2 was used as a positive control during these experiments. Cells were transfected with in vitro transcribed capped RNA and processed for the detection of capsid protein by immunofluorescence assay (IFA) on the 12th day post-transfection. Positive fluorescence, though at a lower level (about 0.5-1 % positive cells) as compared to pSK-HEV2 (about 3-4 % positive cells) (data not shown) could be detected, indicating replication competence of the HEV-4FG. Further, to check for the infectivity of generated HEV particles, HepG2/C3A cells were infected with the transfected S10-3 cell lysates (12 days post-transfection). Cells were processed both for negative sense RNA (nsRNA) assay on the 6th day (post-infection) and for IFA, on the 9th day. Infected HepG2/C3A cells were positive in both IFA and nsRNA assay indicating successful generation of infectious virus particles (results not shown). However, virus was not released into the supernatant and remained cell associated which was also seen for the pSK-HEV2 generated virus. This confirmed successful generation of an infectious cDNA clone of genotype 4 HEV. With these results it was decided that this clone would be used as a parent genotype 4 clone for developing genotype 1/4 chimeric constructs.
Screening of cell lines by transfecting them with HEV genotype 1 and 4 in vitro transcripts
We were in search of a cell line that would support replication of HEV-4 and at the same time would not be permissive for HEV-1. We reasoned that the chimera that would replicate in this cell line would indicate the genomic region responsible for crossing the species barrier. We used detection of nsRNA, replicative intermediates to screen the cell lines. The major reasons were:
1. In our hands we found it to be more sensitive compared with IFA. 2. Cells negative for replicative intermediates would be negative for IFA, so could be excluded from the experimental set up.
Human cell lines already demonstrated to support HEV replication were used for this experiment (human liver origin: HepG2, PLC/PRF/5, Huh7, S10-3 and HepG2/C3A; human lung origin: A549; human colon: Caco2). In the absence of commercial cell lines of swine liver origin, PK-15 (kidney), ESK-4 (embryo) and ST (testes) were screened. PK-15 cells have already been demonstrated to be non-permissive to HEV-1 replication. We thought it would be interesting to check their susceptibility to HEV-4. Susceptibility to HEV-4 and not to HEV-1 would indicate an ideal host for testing chimeras. ESK-4 and ST cells are susceptible to bovine viral diarrhea virus 1 and swine enteroviruses, respectively (Technical sheet, ATCC). We reasoned that since HEV is also an enteric virus, the said cell lines could be susceptible to HEV. Cells were transfected with capped transcripts obtained from both pSK-HEV2 and HEV-4FG clones. Detection of nsRNA intermediates was performed 6, 9 and 12 days post-transfection. All the human cells were positive on the 6th day for pSK-HEV2; positivity could be seen until the 12th day, when the experiment was terminated. All three porcine cell lines transfected with genotype 1 transcripts remained negative in the nsRNA detection assay until 12th day post-transfection. HEV-4 showed positive signals in PLC/PRF/5, Huh7, S10-3, HepG2/C3A, A549, PK-15 and ESK-4 cells on day 9 and remained positive on day 12 (Table 1) . HEV-4 could not establish successful replication in Caco2, HepG2 as these cells remained negative until 12 days post-transfection. This entire experiment was carried out in three sets. However, these two cell lines remained consistently negative. ST cells were extremely sensitive for transfection with RNA, showed considerable cell death and were excluded from further experiments. It has been previously shown that S10-3 cells support efficient replication upon transfection with HEV recombinant genomes [produce infectious virus particles and nearly mimic natural replication cycle of the virus (Graff et al., 2006) ]. Therefore, we decided to use these human cells further to check the replication competence of chimeric HEV clones. Replicative intermediates could be detected much more consistently in PK-15 cells compared with ESK-4. So, PK-15 was used as model porcine cell system.
Evaluation of replication potential of intergenotypic chimeras in vitro
It is known that genotype 4 HEV has the ability to cross species barriers (pig to human or vice versa), whereas genotype 1 HEV is restricted to humans. We felt that development of a chimeric virus with the backbone of the genotype 1 genome would provide insight into the genomic region/s of genotype 4 virus which help in crossing the species barrier. Twelve intergenotypic chimeric constructs were made by replacing: structural region (ORF2 and ORF3); nonstructural region (ORF1); and regulatory regions 5¢ noncoding region (5¢NCR), 3¢ non-coding region (3¢NCR), junction region (JR) of the HEV genotype 1 virus genome with corresponding regions from the genotype 4 virus ( Fig. 1) . PK-15 and S10-3 cells were transfected with capped transcripts obtained from the constructs and processed for IFA, 12 days post-transfection. HEV-4FG and pSK-HEV2, parent constructs were used in all experiments as controls and respective RNA dependent RNA polymerase (RdRp) GAA mutants were used as negative controls for the experiments.
We observed IFA positivity in S10-3 cells with all the chimeras, though the percentage IFA positivity differed significantly. These observations suggest that genomic regions of genotype 1 HEV can be replaced with that of genotype 4 without hampering the in vitro replicative potential. RdRp GAA mutants of both genotype 1 and 4 parental virus constructs remained negative until 12 days in both the cells. All the constructs, except HEV-4FG, HEV-1 (HEV-4 5¢NCR-ORF1) and HEV-1 (HEV-4 ORF1) remained negative in IFA until 12 days post-transfection in PK-15 cells (Fig. 2 , Table 2 ).
HEV-4 non-structural proteins encoded by ORF1 are important for replication in porcine cells
The observation of differential replication competence of different constructs in S10-3 and PK-15 cells was thought to be due to two reasons:
1. Capsid protein synthesis is at a low level. 2. Kidney cells (not being the primary site of infection) are not conducive to a full replication cycle. 
HEV-1 (HEV-4 ORF2) + À Chimera 7
HEV-1 (HEV-4 5¢NCR-JR-ORF2) + À Chimera 8
HEV-1 (HEV-4 ORF2-3¢NCR) + À Chimera 9
HEV-1 (HEV-4 5¢NCR-JR-ORF2-3¢NCR) + À Chimera 10 HEV-1 (HEV-4 JR-3¢NCR) + À Chimera 11
HEV-1 (HEV-4 5¢NCR-ORF1) + + Chimera 12
HEV-1 (HEV-4 ORF1) + + HEV-1 denotes the backbone of genotype 1 HEV and bracket denotes the genotype 4 fragments inserted into the parental backbone.
To confirm the latter possibility, detection of replicative intermediates was tried out. S10-3 and PK-15 cells were transfected in parallel with 2 µg of RNA of all the constructs. Total RNA was isolated from the transfected cells on the 9th day post-transfection and processed for nsRNA detection. For that, RNA was first processed for real time PCR assay to quantify positive sense RNA in the sample. The sample was diluted to reduce positive sense RNA copy number to 10 5 copies per reaction. In accordance to IFA results, except for the GAA RdRp mutants (of pSK-HEV2 and HEV-4FG), all parental and chimeric constructs showed positivity in S10-3 cells, again indicating that they could establish successful replication. For PK-15 cells, again HEV-4FG, and the chimeras HEV-1 (HEV-4 5¢NCR-ORF1) and HEV-1 (HEV-4 ORF1) gave positive results (Fig. 3 , Table 3 ).
The chimera with 5¢NCR of the genotype 4 genome, either alone or in combination with other genotype 4 regions, did not yield positive results in PK-15 cells, indicating the importance of ORF1 in crossing the species barrier.
5¢ and 3¢ NCRs dictate replication efficiency
The chimeras developed by replacing ORF1, ORF2/3 encoding regions and the cis-regulatory genomic elements, 5¢NCR, 3¢NCR and putative sub-genomic promoter (JR) (currently called the junction region rather than the sub-genomic promoter since it is not functionally confirmed) with HEV-4 sequences showed different replication efficiencies when analysed using IFA. To have a more unbiased quantitative measurement of the replicative competence of chimeras developed in this study, we carried out ANOVA analysis using IFA. The null hypothesis that the data was normally distributed was rejected after data analysis (JarqueBera = 241.739; P<0.0001). Leven's test of homogeneity of variance suggested that the variances were equal across the groups (P=1.77Â10
À11
). Since variance tests were found to be significant, we used a non-parametric Kruskal-Wallis test with sequential Bonferroni correction for the comparison of the percentage of HEV-positive cells for different constructs. The ].
Cells transfected with the constructs HEV-1 (HEV-4 JR-ORF2-3¢NCR) and HEV-1 (HEV-4 ORF2-3¢NCR) showed significantly higher HEV-positive cells (Mann-Whitney U test; Bonferroni correction P< 0.0001 each) as compared with other constructs used in this study (Fig. 4) . HEV-1 (HEV-4 5¢NCR), HEV-1 (HEV-4 5¢NCR-ORF1), HEV-1 (HEV-4 ORF1) and HEV-4FG showed significantly lower replication efficiencies as compared with pSK-HEV2 (Mann-Whitney U test, Bonferroni correction P<0.0001 each). Swapping of ORF2, JR-ORF2, JR-3¢NCR or 3¢NCR [chimeras HEV-1 (HEV-4 ORF2), HEV-1 (HEV-4 JR-ORF2), HEV-1 (HEV-4 JR-3¢NCR) and HEV-1 (HEV-4 3¢NCR)] did not change the replication efficiencies of the clones significantly. There was a significant reduction in the replication efficiency of the HEV-1 (HEV-4 5¢NCR) clone compared to the HEV-1 (HEV-4 3¢NCR) clone, however inclusion of both 5¢ and 3¢NCR in the chimera HEV-1 (HEV-4 5¢-3¢NCR) improved replication. Comparable replication efficiencies of the chimeras HEV-1 (HEV-4 5¢NCR-JR-ORF2-3¢NCR), HEV-1 (HEV-4 JR-3¢NCR) and pSK-HEV2, but lower level efficiencies of the chimeras HEV-1 (HEV-4 5¢NCR-JR-ORF2) and HEV-1 (HEV-4 JR-ORF2) suggest a minor role of the junction region in deciding the host-specific replication efficiency. Significantly higher replication efficiencies of the chimeras HEV-1 (HEV-4 JR-ORF2-3¢NCR) and HEV-1 (HEV-4 ORF2-3¢NCR), indicated a critical role of 3¢NCR in regulating host-specific replication. However, replication of the chimera containing 3¢NCR alone, HEV-1 (HEV-4 3¢NCR), was comparable to pSK-HEV2, and significantly less than the HEV-1 (HEV-4 JR-ORF2-3¢NCR) and HEV-1 (HEV-4 ORF2-3¢NCR) clones.
Infectivity of virus particles generated by transfecting S10-3 cells Though S10-3 cells exhibited good transfection efficiency it was not possible to use these cells for evaluating infectivity of virus that was generated after transfection. We have previously infected several cell lines of human origin such as HepG2, PLC/PRF/5, Huh7, S10-3, Caco2 and A549 with genotype 1 virus purified from human stool samples to see their permissiveness (Devhare et al., 2013) and noticed that HepG2/C3A cells become positive for negative strand 8 h post-infection and IFA positive on the 6th day. HepG2/C3A cells have been successfully used by other researchers for HEV infectivity studies (Emerson et al., 2010; Feagins et al., 2011) . Virus particles generated from the chimera HEV-1 (HEV-4 ORF1) would have capsid protein of genotype 1. We hypothesized that infection of PK-15 cells with this virus would help us determine whether the host restriction of Positive cells (%) genotype 1 virus is at the receptor level or whether it is dependent upon the host cell environment (host cell proteins). It was also essential to check whether PK-15 cells were capable of generating infectious viral particles. To analyse this, we decided to transfect PK-15 and S10-3 cells and evaluate the infectivity of the generated virus particles in PK-15 and HepG2/C3A cells. For that, S10-3 and PK-15 cells were transfected (T25 cm 2 flask for each construct) with transcripts generated from the parental genotype 1 and 4 clones and three chimeras, two replicating with significantly higher efficiency compared with pSK-HEV2: HEV-1 (HEV-4 JR-ORF2-3¢NCR) and HEV-1 (HEV-4 ORF2-3¢NCR) and the third chimera, HEV-1 (HEV-4 ORF1), which was successfully replicating in PK-15 cells. Cells were harvested on the 12th day post-transfection, and the cleared lysates were used for infecting both PK-15 and HepG2/C3A cells. Infected cells were monitored by both nsRNA assay as well as IFA for the virus replication.
HepG2/C3A cells infected with the lysates of S10-3 cells transfected with the parent construct pSK-HEV2 and the chimeric construct HEV-1 (HEV-4 JR-ORF2-3¢NCR) were positive for both nsRNA and IFA. HEV-4FG and HEV-1 (HEV-4 ORF2-3¢NCR) were positive only for nsRNA. Chimera HEV-1 (HEV-4 ORF1) was negative for both (Table 4) .
None of the constructs showed IFA positivity in PK-15 cells. However, PK-15 cells infected with HEV-4FG were nsRNA positive indicating successful virus entry. However, PK-15 cells infected with virus particles generated with the chimera HEV-1 (HEV-4 ORF1) were negative in both IFA and nsRNA. HepG2/C3A and PK-15 cells infected with lysates prepared from transfected PK-15 cells also did not show any positivity for nsRNA and IFA.
With these results it was not possible to conclude whether particles generated from HEV-1 (HEV-4 ORF1) chimera were unable to enter into the PK-15 cells or whether very few virus particles were generated in S10-3/PK-15 cells and they were unable to establish successful infection in PK-15 cells.
DISCUSSION
Successful replication of a virus in its host is a complex process which involves multilevel interactions. Viruses and hosts evolve together and this co-evolution often leads to species specificity. The presence of specific attachment proteins/receptors and availability of a complex pool of cellular factors required for viral replication decide the permissiveness of a virus host. Though the structural proteins are involved in receptor binding (capsid/envelope) and are important in entering host cells, non-structural proteins involved in replication can also contribute significantly to deciding host/tissue specificity. Lack of an appropriate cell culture system or small animal model has been the major hurdle to studying the molecular mechanisms of HEV replication, tissue/species specificity, cell surface receptors and immune-pathogenesis of HEV. Genotype 3 and 4 HEV strains were shown to grow efficiently in PLC/ PRF5 cells (Tanaka et al., 2007 ); however, genotype 1 virus still lacks an efficient cell culture system. Infectious cDNA clones have been developed successfully for the genotypes 1, 3 and 4 of the mammalian strains of HEV (Panda et al., 2000; Emerson et al., 2001; Yamada et al., 2009; Córdoba et al., 2012) and used to shed some light on HEV replication. There are a number of studies that have addressed the issue of viral determinants and host specificity in HEV (Córdoba et al., 2012; Feagins et al., 2011; Graff et al., 2005) , but the question is still open. A recent report by Nguyen et al. (2014) suggested that the host restriction for the genotype 1 virus could be due to restricted entry into the host cells and efficiency of the virus to generate ORF2 protein in the given host. Lack of compatibility between cell surface receptors and the receptor binding region (rcp) (456-605 aa) in the capsid protein of the virus was suggested to be the deciding factor for successful infection. Nguyen et al. (2014) used an efficiently replicating genotype 3 virus replicon (P6) developed from the Kernow C-1 virus (Shukla et al., 2012) for developing chimeric genotype 1/3 viral genomes. P6 has a 171 nt insertion (from human S17 ribosomal protein encoding gene) in the Hyper Variable Region (HVR) region. It was previously reported by this group that P6 virus isolated from a chronic HEV patient can cross the species barrier (Shukla et al., 2011) . Further, it was shown that the SAR55/S17 chimera can replicate in LLC-PK (pig) cells. Use of a P6 virus clone to develop the SAR55/P6 (genotype 1/3) chimeras in the first place was not a very suitable model to study species specificity since the virus had the ability to infect cells from a broad spectrum of 
species, ranging from rodent to primate. Further, selective growth of the SAR55/P6-rcp chimera in HepG2/C3A cells but not in LLC-PK cells suggested a possible role for additional factor/s other than just the receptor binding region in the capsid protein in deciding host specificity.
We attempted to answer this question by constructing genotype 1/4 chimeras. In the first phase, our aim was to construct a replication competent cDNA clone of HEV genotype 4 and then construct chimeras by replacing parts of genotype 1 with corresponding parts of genotype 4 and check their species specificity using human and swine cell lines.
Construction of full genome infectious clones had many difficulties, the major one being single nucleotide mutations introduced during conventional cloning, which in turn led to reduced/total loss of replication efficiency. In addition to mutations in the ORF1 region, we found an additional eight mutations in the ORF2 encoding region of HEV-4 FG (synonymous: T5775C, T7152 and non-synonymous: A5267G, A5801G, T6355A, C6719T, T6899C, T6929C). We considered that as ORF1 is the non-structural region it would contribute more to replication competence compared with ORF2. So we repaired the mutations in ORF1 to its prototype. However, Emerson et al. (2013) Graff et al. (2005) have shown that there is a significant decrease in HEV replication with a single nucleotide change at 7106 nt in the 3¢NCR of pSK-HEV2, proving that sequences or structures in the 3¢ terminal region are critical for HEV replication. Similarly, with specific binding of the ORF2 protein to the 5¢end of the HEV genome, the importance of 5¢NCR in encapsidation has also been demonstrated (Surjit et al., 2004) .
Considering these facts, we developed HEV-1/HEV-4 chimeras by replacing ORF1, ORF2/3 encoding regions and the cis-regulatory genomic elements, 5¢NCR, 3¢NCR and JR with HEV-4 sequences. Replication efficiencies of these chimeras in S10-3 cells, as seen with the IFA, were not similar. Replacement of ORF2, JR-ORF2, JR-3¢NCR, 3¢NCR [chimeras HEV-1 (HEV-4 ORF2), HEV-1 (HEV-4 JR-ORF2), HEV-1 (HEV-4 JR-3¢NCR), HEV-1 (HEV-4 3¢NCR)] did not change replication efficiencies of the clones. However, chimeras HEV-1 (HEV-4 JR-ORF2-3¢NCR) and HEV-1 (HEV-4 ORF2-3¢NCR) were replicating with higher efficiency than the parental clone pSK-HEV2. When compared with the HEV-1 (HEV-4 3¢NCR) clone, there was a significant reduction in replication efficiency of the HEV-1 (HEV-4 5¢NCR) clone, indicating a major role for 5¢NCR during virus replication. It is likely that specific host proteins interact with the 3¢end of the negative sense antigenome to help initiate synthesis of genomic positive sense molecules.
Improvement in the replication efficiency after inclusion of 3¢NCR in the chimera HEV-1 (HEV-4 5¢-3¢ NCR) further complicated the analysis. We speculate that the HEV 5¢-and 3¢NCRs may either directly interact with each other or via viral/host-cell proteins during replication. Significantly higher replication efficiencies of the chimeras HEV-1 (HEV-4 JR-ORF2-3¢NCR) and HEV-1 (HEV-4 ORF2-3¢NCR) indicated a critical role for 3¢NCR in regulating hostspecific replication. However, since replication of the chimera HEV-1 (HEV-4 3¢NCR) was significantly lower than the HEV-1 (HEV-4 JR-ORF2-3¢NCR) and HEV-1 (HEV-4 ORF2-3¢NCR) clones, we speculate that binding of the host proteins was probably more effective in the presence of respective ORF2 sequences from the same genotype (probably via RNA elements such as SL1 and SL2).
The role of the junction region cannot be completely neglected since chimera HEV-1 (HEV-4 JR-ORF2-3¢NCR) replicated more efficiently than the HEV-1 (HEV-4 ORF2-3¢NCR). The junction region has been shown to influence HEV replication (Cao et al., 2010) , but one more chimera HEV-1 (HEV-4 JR) would perhaps shed more light on this matter.
These results indicate that host proteins can bind to 3¢NCR alone and/or require compatible 5¢-and 3¢NCR. Our results suggest compatibility of 5¢NCR of the genotype 1 and 3¢NCR of the genotype 4 viral genomes. Reverse interaction is probably not very successful, as the chimera HEV-1 (HEV-4 5¢NCR) replicated with very low efficiency. Other chimeras, such as the HEV-1 (HEV-4 3¢NCR-5¢NCR) and HEV-1 (HEV-4 5¢NCR-JR-ORF2-3¢NCR), harbouring 5¢NCR could replicate with better efficiency, perhaps due to the presence of compatible genotype 4 NC regions. The clone HEV-1 (HEV-4 5¢NCR-ORF1) probably replicated with very low efficiency due to the presence of non-compatible 5¢NCR.
HEV-4FG was positive for both nsRNA and IFA in transfected PK-15 cells. Similarly, HEV-1 (HEV-4 5¢NCR-ORF1) and HEV-1 (HEV-4 ORF1) were also positive for both IFA and nsRNA in PK-15 cells upon transfection. These results compel us to conclude that ORF1 may be the region responsible for deciding the species barrier. ORF1 encodes non-structural proteins of the virus and viral nonstructural proteins are known to interact with host cell proteins and modulate host cell environment (Ayllon et al., 2015; Marascio et al., 2014) . When PK-15 and HepG2/C3A cells were infected with virions generated from the above three constructs, only the HEV-4FG construct showed positive results (only nsRNA positive), while other constructs remained completely negative. These results indicate that HEV-1 (HEV-4 5¢NCR-ORF1) and HEV-1 (HEV-4 ORF1) constructs probably generated a very small number of virions which were not able to establish successful infection in new cells. We still believe that using a porcine liver cell line would shed better light.
Even though in vitro transcribed RNA was rendered negative for template DNA, quantitative PCR was not helpful. Present cell culture systems for genotype 1 HEV are not robust and the presence of a large amount of input RNA in cell transfections leads to high background of this RNA and its degradation products. Any marginal change due to newly synthesized RNA is not significant and hence we did not use real-time PCR to evaluate replication efficiencies of the replicons. Further, virus particles of genotype 1 HEV generated after RNA transfections remain cell-associated . So we resorted to IFA and statistics as our tool to compare replication efficiencies of the constructs. Focus forming assay (variant of IFA) has been successfully used for comparing the infectivity titres of hepatitis E virions recently (Nguyen et al., 2014) .
pSK-HEV2 is known not to infect swine cells (Nguyen et al., 2014) . Our observation was similar. It was surprising that HEV-1 (HEV-4 JR-ORF2-3¢NCR) virus behaved similarly, as it had the capsid region of genotype 4 and was expected to infect PK-15 cells, if the restriction was at the capsid protein level (receptor binding). This chimeric virus also failed to establish replication when we directly transfected PK-15 cells with the capped genomes. However, at this juncture we cannot comment on the receptor-based barrier as none of our chimeras were able to infect PK-15 cells. We speculate that the barrier could be both at the receptor level and non-conducive cell milieu. It would be interesting to see how the HEV-4 FG and the chimeras HEV-1 (HEV-4 5¢NCR-ORF1), HEV-1 (HEV-4 ORF1) behave in an efficient pig cell culture system. It would be worthwhile to see infectivity of these clones in pigs by direct intra-hepatic inoculations.
METHODS
Ethics statement. All experimental protocols were reviewed and approved by the Institutional Biosafety Committee (IBSC) of the National Institute of Virology (NIV), Pune, India. All experiments were carried out in strict accordance with good laboratory practices as defined by the IBSC in BSL2 laboratory. streptomycin. Cells were grown at 37 C in the presence of 5 % CO 2 . Transfected/infected cells were incubated at 34.5 C. Stool suspension containing Indian swine HEV (GenBank accession no. AY723745) was used as the source of genotype 4 virus.
Construction of HEV genotype 4 full genome clone. Total RNA was isolated from 10 % stool suspension of a pig stool sample containing genotype 4 virus. Five overlapping fragments encompassing the entire viral genome were amplified by PCR using five different sets of PCR primers (Table S1 , available in the online Supplementary Materials) and TA-cloned into pGEMT-EASY vector (Promega, USA). Clone numbers 1, 2, 3, 4 and 5 contained fragments representing 1-387, 102-2177, 1848-4694, 3924-6317 and 5728-7214 nt in the genotype 4 genome, respectively. Fragment 1 (1-387) was initially amplified from source using 5¢RACE (Ambion, USA). It was later re-amplified with forward primer T7F containing a T7 promoter sequence at the extreme 5¢ end of the viral genome. For the assembly of the full genome clone, TA clones of the individual fragments were assembled stepwise using unique restriction sites in the genome. Briefly, clone 1 and 2 were assembled using PstI and SmaI sites to generate clone 6. Clone 3 and clone 6 were assembled using KpnI and NotI sites to generate clone 7. Clone 4 and clone 5 were processed with KpnI and PstI and ligated to generate clone 8. Clone 7 and 8 were linearized with PstI, treated with shrimp alkaline phosphatase and ligated to generate the full genome clone, HEV-4FG. The clone was confirmed by sequencing. The sequence was compared with the original sequence which was directly generated from PCR amplicons and mutations were corrected by carrying out multiple, stepwise site-directed mutagenesis reactions.
Construction of replication-deficient full genome clones. RNAdependent RNA polymerase (RdRp) mutants (GDD to GAA) were constructed for the parental full genome constructs pSK-HEV2 and HEV-4FG. Mutations in this conserved motif have been shown to abolish HEV replication (Emerson et al., 2004) and thus were used as negative controls.
Construction of chimeras. For the development of genotype 1/4 chimeric constructs, genotype 1 complete cDNA clone pSK-HEV2 was used as the backbone. Genotype 4 HEV full-genome clone was used as the template for amplifying different genomic regions which were replaced from the pSK-HEV2 (Fig. 1) . Multiple strategies such as sitedirected mutagenesis, fusion PCR and unique restriction sites were used to facilitate the replacement of designated genes of genotype 1 (HEV-1) virus with corresponding genes from the genotype 4 virus (HEV-4). To construct Chimera 1: HEV-1 (HEV-4 3¢NCR) 3¢NCR of genotype 1 genome was replaced with the corresponding region of HEV-4. Chimera 4: HEV-1 (HEV-4 5¢NCR) was constructed by site-directed mutagenesis of the original pSK-HEV2 (HEV-1) clone. Chimera 5: HEV-1 (HEV-4 5¢NCR-3¢NCR) was developed by site-directed mutagenesis of Chimera 1. Junction region (JR), ORF3 and ORF2 with or without 3¢NCR were replaced in the place of corresponding regions of HEV-1 clone to produce Chimera 2: HEV-1 (HEV-4 JR-ORF2) and Chimera 3: HEV-1 (HEV-4 JR-ORF2-3¢NCR). Site-directed mutagenesis was performed on the Chimeras 2 and 3 to generate Chimera 7: HEV-1 (HEV-4 5¢NCR-JR-ORF2) and Chimera 9: HEV-1 (HEV-4 5¢NCR-JR-ORF2-3¢NCR), respectively. To generate Chimera 6: HEV-1 (HEV-4 ORF2) and Chimera 8: HEV-1 (HEV-4 ORF2-3¢NCR), the junction region of chimera 2 and 3 constructs was changed back to HEV-1. ORF1 along with adjacent 5¢NCR was replaced with the corresponding region of HEV-4 to construct Chimera 11: HEV-1 (HEV-4 5¢NCR-ORF1). Chimera 10: HEV-1 (HEV-4 JR-3¢NCR) and Chimera 12: HEV-1 (HEV-4 ORF1) were constructed by carrying out site-directed mutagenesis of the Chimera 1 and Chimera 11 constructs, respectively. All generated constructs were confirmed by sequencing before proceeding with the further experiments.
Generation of full length RNA. The full genome chimeric virus encoding plasmids were linearized utilizing restriction enzyme sites BglII (pSK-HEV2 and Chimeras) or BamHI (HEV-4FG), present at the 3¢ end of the respective full genome clones. The linearized DNA was used as the template to generate full genome long transcripts using T7 promoter incorporated at the 5¢ end of the HEV genome with in vitro transcription kit (mMESSAGE m Machine T7 ultra kit, Ambion, USA). Briefly, 11 µl 2Â NTP/ARCA mix, 2.0 µl 10Â buffer, 2.0 µl enzyme mix were mixed with 5.0 µl template DNA (2.0 µg) and incubated at 37 C for 2 h. Plasmid DNA was removed by adding 5 µl (1 unit/µl) of RQ1 RNase-free DNase I (Promega, USA) and incubated at 37 C for 30 min. RNA was precipitated using 7.5 M LiCl and the pellet was washed with 70 % ethanol, air dried and dissolved. A second round of DNase treatment was given with Turbo DNase (2 units/µl) (Ambion, USA) at 37 C for 1 h for complete removal of the DNA template wherever required. RNA was purified by phenol chloroform extraction and dissolved in RNase-free water. The concentration of RNA was determined spectrophotometrically using Nanodrop (ND-1000) at 260 nm; RNA integrity was checked by denaturing agarose gel electrophoresis. RNA was aliquoted and stored at À80 C until required.
Degradation of template DNA. Reports suggest incomplete degradation of template DNA in the presence of excess of product RNA in transcription mixtures. To confirm this possibility, equal amounts of RNA (2 µg) used for transfection was processed for nested PCR (using primers for negative strand detection) without using reverse transcriptase. Suitable positive controls were also processed simultaneously. Only after confirming complete removal of template DNA (negative for PCR), was RNA used for cell transfection.
Transfection of cell lines with in vitro transcribed RNA. Cells (0.75Â10 5 /well) were plated in a 24-well plate (Corning, USA) 24 h prior to transfection and incubated at 37 C. Cells were washed three times with Opti-MEM (Invitrogen, Life Technologies, USA), 2 µg of in vitro transcribed RNA was mixed with 2 µl of 1,2-dimyristyl Rosenthal inhibitor ether (DMRIE-C) transfection reagent (Invitrogen, USA) in 200 µl of Opti-MEM and layered on cells. Cells were incubated at 34.5 C for 5 h. Transfection mixture was replaced with complete medium without antibiotics and further incubation was carried out at 34.5 C. All transfections were carried out in triplicate.
Immunofluorescence assay (IFA). To check replication competence of constructs, transfected cells were checked for the presence of capsid protein by IFA. Assays were performed 12 days post-transfection. For that, transfected cells were trypsinized on day 11 and plated in each well of an eight-well chambered glass slide (Nunc, Germany). After incubation for 24 h, medium was removed, the cell layer was washed once in 1Â PBS and fixed in acetone at room temperature for 2 min. Cells were hydrated in 1Â PBS followed by layering with 200 µl of the blocking buffer (Super block) (Pierce, USA) and incubation at room temperature for 30 min in a humid chamber. Polyclonal primary antibody (anti-HEV IgG antibody positive: human serum) was diluted (1:100) in blocking buffer (0.5 % BSA, 0.5 % milk powder and 0.1 % Triton X-100 in PBS), added and incubation was carried out at room temperature for 30 min. The human serum (primary antibody) was selected after screening in ELISAs which used recombinant ORF2 and ORF3 proteins, respectively, as coating antigens. The serum was positive only for anti-ORF2 and negative for anti-ORF3 antibodies. After incubation with the primary antibody, cells were washed and the secondary antibody, anti-human IgG tagged with Alexa Fluor 488 in blocking buffer [1 : 2000 dilution (stock: 2 mg ml À1 )], was overlaid on the cells. After incubating at room temperature for 30 min, and after washing cells, a coverslip was laid with 10 µl of mounting fluid (Chemicon) and analysed under inverted fluorescence microscope (Axioscope, Carl Zeiss, Imager A.2, Germany) at 200Â magnification. Parameters were set to differentiate between positive and negative IFA signals. For each slide 15-20 fields were randomly selected and images were taken. Image acquisition was carried out using 'ProgRes capture Pro 2.8'.
Quantitative PCR. Total cellular RNA was extracted from transfected and infected cells with Ribopure RNA extraction kit (Ambion, Life technologies, USA) as per the manufacturer's instructions. RNA was eluted in nuclease-free water. Quantitation of RNA was done using Nanodrop at 260 nm. RNA was aliquoted and stored at À80 C until required. HEV RNA copies in the samples were determined by Taqman Real-time PCR assay using 7300 Real Time PCR system (Applied Biosystems, CA, USA) as described previously (Arankalle et al., 2009) . Separate sets of primers, probes specific for pSK-HEV2 and HEV-4, were used for different constructs as required (Table S2 and Table S3 ).
Detection of replicative intermediates (negative sense RNA) in the transfected/infected cells. Total cellular RNA was extracted from cells using Ribopure RNA extraction kit (Ambion) and detection of negative sense RNA (nsRNA) (replicative intermediate) was done as described previously (Chatterjee et al., 2012) using tagged primer-based reverse-transcription PCR. A separate set of primers, specific for pSK-HEV2 and HEV-4, were used (Table S4 ). Before proceeding with the nsRNA detection, all RNA samples were processed for positive sense HEV RNA quantitation. Samples were diluted to reduce input positive sense RNA copies to 10 5 copies/reaction to avoid false positivity.
Preparation of cell lysates and in vitro infectivity assays. Confluent monolayers of cells transfected with RNA (25 cm 2 flask) were harvested 12 days post-transfection by trypsinization, centrifuged for 2 min at 2000 rpm. Supernatant was aspirated, and the cell pellet was stored at À80 C. For preparing cell lysate, frozen cell pellets were extracted at room temperature by adding 0.45 ml of water and vortexing vigorously until the pellet dispersed and the solution became cloudy. The sample was vortexed once or twice more in the next 10 min, 0.05 ml of 10Â PBS was added, and debris was removed by centrifugation at 16 000 g for 2 min. HepG2/C3A and PK-15 cells were plated (0.75Â10 6 per well) on an eight-well glass chamber slide (Nunc, Denmark) and 24-well plate, 24 h prior to infection. Next day, cells were washed three times with incomplete DMEM and then incubated with 100 µl of cell lysate at 34.5 C in a 5 % CO 2 atmosphere for 5 h. Liquid was aspirated and replaced with 0.4 ml of growth medium containing antibiotics. Cells from 24-well plate were harvested on the 6th day for RNA negative strand detection. Chamber slides were processed for IFA on the 7th day. Cells were infected keeping the cell-to-cell ratio the same (cell lysate generated from a well of a 24-well plate was used for the infection of cells seeded in a single well of a 24-well plate).
